Insider · CIK 0001250661
Mark Corrigan
director
Files at WVE (Wave Life Sciences Ltd.). First filing Dec 10, 2025, latest Dec 10, 2025.
Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 1
$0 bought, $217k sold
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
WVE: Wave Life Sciences Ltd.
WVEOct 9, 2026 · close 3.46
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 32Weak | Wave Life Sciences Ltd. | $217k 16,115 shares | -36% | +238% from low0% from high |
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Oct 5, 2026 | WVE Wave Life Sciences Ltd. | AGrant or award Common Stock | +10,700 | $0.00 | $0 | 39,515 | 5 d ago |
| Oct 5, 2026 | WVE Wave Life Sciences Ltd. | AGrant or award Stock Option (right to buy)derivative | +64,000 | $0.00 | $0 | 64,000 | 5 d ago |
| Dec 8, 2025 | WVE Wave Life Sciences Ltd. | SOpen-market sale Ordinary Shares10b5-1 | -9,600 | $13.09 | $126k | 35,330 | Dec 10, 2025 |
| Dec 8, 2025 | WVE Wave Life Sciences Ltd. | SOpen-market sale Ordinary Shares10b5-1 | -6,515 | $14.07 | $92k | 28,815 | Dec 10, 2025 |
| Aug 11, 2025 | WVE Wave Life Sciences Ltd. | AGrant or award Ordinary Shares | +12,700 | $0.00 | $0 | 44,930 | Aug 13, 2025 |
| Aug 11, 2025 | WVE Wave Life Sciences Ltd. | AGrant or award Share Option (right to buy)derivative | +76,200 | $0.00 | $0 | 76,200 | Aug 13, 2025 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.